BGI Genomics Co Ltd
SZSE:300676

Watchlist Manager
BGI Genomics Co Ltd Logo
BGI Genomics Co Ltd
SZSE:300676
Watchlist
Price: 39.16 CNY -0.03%
Market Cap: 16.3B CNY

Wall Street
Price Targets

Price Targets Summary
BGI Genomics Co Ltd

There are no price targets for BGI Genomics Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BGI Genomics Co Ltd Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
217% Upside
PYC
PYC Therapeutics Ltd
209% Upside
ALERS
Eurobio Scientific SA
21% Upside
PHM
Pharma Mar SA
3% Downside
300601
Shenzhen Kangtai Biological Products Co Ltd
45% Upside
AMGN
Amgen Inc
21% Upside
BMRN
Biomarin Pharmaceutical Inc
61% Upside
AGIO
Agios Pharmaceuticals Inc
88% Upside

Revenue
Forecast

Revenue Estimate
BGI Genomics Co Ltd

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's revenue is 16%. The projected CAGR for the next 2 years is 6%.

16%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BGI Genomics Co Ltd

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's operating income is -7%. The projected CAGR for the next 5 years is 35%.

-7%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BGI Genomics Co Ltd

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's net income is -12%. The projected CAGR for the next 2 years is 38%.

-12%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGI Genomics Co Ltd's stock price target?
Not Available

BGI Genomics Co Ltd doesn't have any price targets made by Wall Street professionals.

What is BGI Genomics Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's revenue is 16%. The projected CAGR for the next 2 years is 6%.

What is BGI Genomics Co Ltd's Operating Income forecast?
Projected CAGR
35%

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's operating income is -7%. The projected CAGR for the next 5 years is 35%.

What is BGI Genomics Co Ltd's Net Income forecast?
Projected CAGR
38%

For the last 8 years the compound annual growth rate for BGI Genomics Co Ltd's net income is -12%. The projected CAGR for the next 2 years is 38%.

Back to Top